CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
Phenylephrinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00838695
NCT00838695N/ACompleted
CompareCT.gov

Variability in Adrenergic Response

Vanderbilt University·interventional·Posted Feb 6, 2009·Updated Oct 26, 2018

In Brief

A clinical study evaluating Phenylephrine for Vascular Reaction to Medications. Completed, enrolled 106 participants across 1 site.

Detailed Summary

The goal of this project is to determine the genetic factors contributing to interindividual differences in response to physiological and pharmacological vasoconstrictors and vasodilators.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVascular Reaction to Medications
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), National Center for Research Resources (NCRR)

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 6, 2009
Enrollment StartJan 1, 2009
Primary CompletionDec 1, 2010
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 17.4 years ago

Interventions

Phenylephrinedrug

Intravenous phenylephrine at low doses (approximately 10 doses ranging from 0-5000 ng/min) Intravenous nitroglycerin at low doses (approximately 10 doses ranging from 0.05-100 ng/min)